Karin A. Kook
- Molecular Biology
- Physiology top 5%
- Nephrology top 2%
- Surgery top 10%
- Pharmacology top 5%
- Co-authors
- Robert TerkeltaubDaniel E. FurstMatthew W. DavisR. S. CrockettKatherine BennettSteve D. ThomasPeter BenthamClaude M. Wischik
- Topics
- Multiple Myeloma Research and Treatments (6 papers)Alzheimer's disease research and treatments (3 papers)Neuroscience and Neuropharmacology Research (3 papers)
- Journals
- The LancetBloodBrain Research
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Karin A. Kook
21 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Molecular Biology 516
- Physiology 485
- Nephrology 370
- Surgery 310
- Pharmacology 284
Countries citing papers authored by Karin A. Kook
This map shows the geographic impact of Karin A. Kook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin A. Kook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin A. Kook more than expected).
Fields of papers citing papers by Karin A. Kook
This network shows the impact of papers produced by Karin A. Kook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin A. Kook. The network helps show where Karin A. Kook may publish in the future.
Co-authorship network of co-authors of Karin A. Kook
This figure shows the co-authorship network connecting the top 25 collaborators of Karin A. Kook. A scholar is included among the top collaborators of Karin A. Kook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin A. Kook. Karin A. Kook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | 5 | |
| 3 | 33 | |
| 4 | Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trialbreakdown → | 321 |
| 5 | 199 | |
| 6 | 175 | |
| 7 | 351 | |
| 8 | 35 | |
| 9 | 108 | |
| 10 | 43 | |
| 11 | 105 | |
| 12 | 25 | |
| 13 | 67 | |
| 14 | 58 | |
| 15 | 23 | |
| 16 | 24 | |
| 17 | 44 | |
| 18 | 31 | |
| 19 | 100 | |
| 20 | 17 |
About Karin A. Kook
Karin A. Kook is a scholar working on Hematology, Neurology and Virology, having authored 21 papers that have together received 1.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Alzheimer's disease research and treatments (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). The work is most often cited by research in Nephrology (370 citations), Biological Psychiatry (75 citations) and Hematology (231 citations). Karin A. Kook has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Robert Terkeltaub, Daniel E. Furst, Matthew W. Davis, R. S. Crockett, Katherine Bennett, Steve D. Thomas, Peter Bentham, Claude M. Wischik, Steve K. Teo and Charles R. Harrington. Their work appears in journals such as The Lancet, Blood and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.